251 - 260 of 8399 Results
Title
Year
-
OPENTitle: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samplesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci183592Citation Count: 0
-
OPENTitle: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental ApproachJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 1Start Page: 9End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms26010009Best OA location URL: https://doi.org/10.3390/ijms26010009Citation Count: 1
-
OPENTitle: Non-motor asymmetry and dopamine degeneration in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf002Citation Count: 0
-
OPENTitle: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 97Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.27158Best OA location URL: https://doi.org/10.1002/ana.27158Citation Count: 0
- Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia2024OPENTitle: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14448Citation Count: 0
-
OPENTitle: α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease PatientsJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30094Best OA location URL: https://doi.org/10.1002/mds.30094Citation Count: 1
-
OPENTitle: In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae404Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae404/61249433/awae404.pdfCitation Count: 0
-
OPENTitle: Machine Learning Recognizes Stages of Parkinson’s Disease Using Magnetic Resonance ImagingJournal Name: SensorsPublisher: MDPI AGVol: 24Issue #: 24Start Page: 8152End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s24248152Best OA location URL: https://doi.org/10.3390/s24248152Citation Count: 0
-
RESTRICTED
-
OPENTitle: Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brainJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14401Best OA location URL: https://doi.org/10.1002/alz.14401Citation Count: 2